SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ryan DH, Espeland MA, Foster GD et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003; 24: 610628.
  • 2
    Gregg EW, Williamson DF. Relationship of intentional weight loss to disease incidence and mortality. In: Wadden TA, Stunkard AJ (eds). Handbook of Obesity Treatment. Guilford Press: New York, 2002, pp 125143.
  • 3
    Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF. Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Ann Intern Med 2003; 138: 383389.
  • 4
    Look AHEAD Research Group. Pi-Sunyer X, Blackburn G et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007; 30: 13741383.
  • 5
    Wing RR, Hamman RF, Bray GA et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res 2004; 12: 14261434.
  • 6
    Wing RR, Anglin K. Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care 1996; 19: 409413.
  • 7
    Kumanyika SK, Espeland MA, Bahnson JL et al. Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly. Obes Res 2002; 10: 96106.
  • 8
    Wadden TA, Foster GD, Wang J et al. Clinical correlates of short- and long-term weight loss. Am J Clin Nutr 1992; 56: 271S274S.
  • 9
    Jeffery RW, Bjornson-Benson WM, Rosenthal BS et al. Correlates of weight loss and its maintenance over two years of follow-up among middle-aged men. Prev Med 1984; 13: 155168.
  • 10
    UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type II diabetes (UKPDS 34). Lancet 1998; 352: 854865.
  • 11
    Fritsche A, Haring H. At last a weight neutral insulin? Int J Obes Relat Metab Disord 2004; 28: S41S46.
  • 12
    Carver C. Insulin treatment and the problem of weight gain in type 2 diabetes. Diabetes Educ 2006; 32: 910917.
  • 13
    Look Ahead Research Group. Bray G, Gregg E et al. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006; 3: 202215.
  • 14
    Jakicic JM, Balasubramanyam A, Bancroft B et al. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: Results from the Look AHEAD study. Int J Obes Relat Metab Disord, in press.
  • 15
    Look AHEAD Research Group. Wadden TA, West DS et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) 2006; 14: 737752.
  • 16
    The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393403.
  • 17
    The Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP). Description of lifestyle intervention. Diabetes Care 2002; 25: 21652171.
  • 18
    Kumanyika SK. Obesity treatment in minorities. In: Wadden TA, Stunkard AJ (eds). Handbook of Obesity Treatment. Guilford Press: New York, 2002, pp 416446.
  • 19
    Kumanyika SK, Espeland MA, Bahnson JL et al. Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly. Obes Res 2002; 10: 96106.
  • 20
    Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight loss effects of long-term dietary intervention in obese subjects. Am J Clin Nutr 1999; 69: 198204.
  • 21
    Heymsfeld SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement strategy: Meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 2003; 27: 537549.
  • 22
    Metz J, Kris-Etherton P, Morris C et al. Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am J Clin Nutr 1997; 66: 373385.
  • 23
    Wing RR, Jeffery RW, Burton LR et al. Food provision vs. structured meal plans in the behavioral treatment of obesity. Int J Obes Relat Metab Disord 1996; 20: 5662.
  • 24
    Flechtner-Mors M, Ditschuneit H, Johnson T, Suchard M, Adler G. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes Res 2000; 8: 399402.
  • 25
    Rolls B, Barnett R. Volumetrics: Feel Full on Fewer Calories. Harper Collins Publishers: New York, 2000.
  • 26
    Perri MG, McAllister D, Gange J et al. Effects of four maintenance programs on the long-term management of obesity. J Consult Clin Psychol 1988; 56: 529534.
  • 27
    West DS, DiLillo V, Bursac Z, Gore SA, Greene PG. Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care 2007; 30: 10811087.
  • 28
    Smith DE, Heckemeyer CM, Kratt PP, Mason DA. Motivational interviewing to improve adherence to a behavioral weight-control program for older obese women with NIDDM. A pilot study. Diabetes Care 1997; 20: 5254.
  • 29
    Sjostrom L, Rissanen A, Anderson T et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 167172.
  • 30
    Hill J, Hauptman J, Anderson J et al. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr 1999; 69: 11081116.
  • 31
    Wadden TA, Berkowitz RI, Womble L et al. Effects of sibutramine plus orlistat in obese women following 1 year treatment by sibutramine alone: a placebo-controlled trial. Obes Res 2000; 8: 431437.
  • 32
    Jeffrey RW, Wing RR, Sherwood NE, Tate DF. Physical activity and weight loss: does prescribing higher physical activity goals improve outcome? Am J Clin Nutr 2003; 78: 684689.
  • 33
    Jakicic JM, Marcus BH, Gallagher KI, Napolitano M, Lang W. Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial. JAMA 2003; 290: 13231330.
  • 34
    Wadden TA, Vogt RA, Andersen RE et al. Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite, and mood. J Consult Clin Psychol 1997; 62: 269277.
  • 35
    Perri MG, Nezu AM, Patti ET, McCann KL. Effect of length of treatment on weight loss. J Consult Clin Psychol 1989; 57: 450452.
  • 36
    Jones A, Shen W, St-Onge MP et al. Body composition differences between African American and white women: relation to resting energy requirements. Am J Clin Nutr 2004; 79: 780786.
  • 37
    Weinsier RL, Hunter GR, Zuckerman PA et al. Energy expenditure and free living physical activity in black and white women: comparison before and after weight loss. Am J Clin Nutr 2000; 71: 11381146.
  • 38
    Jakicic JM, Wing RR. Differences in resting energy expenditure in African American vs Caucassian overweight females. Int J Obes Relat Metab Disord 1998; 22: 236242.
  • 39
    Foster GD, Wadden TA, Swain RM et al. Changes in resting energy expenditure after weight loss in obese African American and white women. Am J Clin Nutr 1999; 69: 1317.
  • 40
    Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res 2005; 13: 18491863.